{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:15:02Z","timestamp":1768778102216,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00392-013-0541-x","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T10:40:14Z","timestamp":1360147214000},"page":"391-393","source":"Crossref","is-referenced-by-count":6,"title":["Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?"],"prefix":"10.1007","volume":"102","author":[{"given":"Michele","family":"Correale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deodata","family":"Montrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Ieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natale Daniele","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,7]]},"reference":[{"key":"541_CR1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.healun.2011.12.011","volume":"31","author":"R Badagliacca","year":"2012","unstructured":"Badagliacca R, Pezzuto B, Poscia R, Mancone M, Papa S, Marcon S, Valli G, Sardella G, Ferrante F, Iacoboni C, Parola D, Fedele F, Vizza CD (2012) Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral. J Heart Lung Transplant 31:364\u2013372","journal-title":"J Heart Lung Transplant"},{"key":"541_CR2","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, SHIFT Investigators (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875\u2013885","journal-title":"Lancet"},{"key":"541_CR3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00392-011-0323-2","volume":"100","author":"S Nuding","year":"2011","unstructured":"Nuding S, Ebelt H, Hoke RS, Krummenerl A, Wienke A, M\u00fcller-Werdan U, Werdan K (2011) Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I(f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial. Clin Res Cardiol. 100:915\u2013923","journal-title":"Clin Res Cardiol."},{"key":"541_CR4","doi-asserted-by":"crossref","unstructured":"De Santis V, Vitale D, Santoro A, Magliocca A, Porto AG, Nencini C, Tritapepe L (2012) Ivabradine: potential clinical applications in critically ill patients Clin Res Cardiol (2012 Oct 14 Epub ahead of print)","DOI":"10.1007\/s00392-012-0516-3"},{"key":"541_CR5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00392-012-0436-2","volume":"101","author":"R Zhang","year":"2012","unstructured":"Zhang R, Bobylev D, Stiefel P, Haverich A, Bara C (2012) Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study. Clin Res Cardiol. 101:631\u2013636","journal-title":"Clin Res Cardiol."},{"key":"541_CR6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00392-010-0208-9","volume":"99","author":"D Vitale","year":"2010","unstructured":"Vitale D, De Santis V, Guarracino F, Fontana A, Pellegrini F, Tritapepe L (2010) Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery. Clin Res Cardiol. 99:853\u2013855","journal-title":"Clin Res Cardiol."},{"key":"541_CR7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00392-012-0437-1","volume":"101","author":"M Correale","year":"2012","unstructured":"Correale M, Montrone D, Di Biase M, Brunetti ND (2012) Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension. Clinic Res Cardiol. 101:593\u2013594","journal-title":"Clinic Res Cardiol."},{"key":"541_CR8","doi-asserted-by":"crossref","unstructured":"Correale M, Montrone D, Ieva R, Di Biase M, Brunetti ND (2012) Ivabradine in systemic sclerosis related pulmonary arterial hypertension. Eur J Intern Med (2012 Sep 25 Epub ahead of print)","DOI":"10.1016\/j.ejim.2012.09.008"},{"key":"541_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCHEARTFAILURE.111.964494","volume":"5","author":"FS Man de","year":"2012","unstructured":"de Man FS, Handoko ML, van Ballegoij JJ, Schalij I, Bogaards SJ, Postmus PE, van der Velden J, Westerhof N, Paulus WJ, Vonk-Noordegraaf A (2012) Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail. 5:97\u2013105","journal-title":"Circ Heart Fail."},{"key":"541_CR10","first-page":"41","volume":"52","author":"\u00c9K Akhmetzianova","year":"2012","unstructured":"Akhmetzianova \u00c9K, Ga\u012dnitdinova VV, Bakirov AB, Bogoroditskaia OA, Timershina IR (2012) Effect of ivabradine on pulmonary hypertension in chronic obstructive pulmonary disease. Kardiologiia. 52:41\u201346","journal-title":"Kardiologiia."}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-013-0541-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-013-0541-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-013-0541-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T09:45:53Z","timestamp":1562665553000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-013-0541-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,7]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["541"],"URL":"https:\/\/doi.org\/10.1007\/s00392-013-0541-x","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,7]]}}}